Solution 'desperately required' for 'serious problem' with medtech standards in EU
This article was originally published in SRA
Executive Summary
The European Commission's approach towards adopting international medical device standards has been too strict over the past few years and is causing a "serious problem" for the medtech sector, according to an independent report carried out on behalf of the commission1. There are concerns that if the situation does not improve, harmonized European standards (hEN) may ultimately no longer be the preferred route for companies to show compliance with the essential requirements of the EU medical device directives.
You may also be interested in...
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.